Skip to main content Skip to main menu
UF Health University of Florida
Department of Neurology College of Medicine
Join Our Team!
Camille L Swartz

Camille L Swartz,

Clinical Research Coordinator III

Department: MD-NEUROLOGY-MOVEMENT DISORDER
Business Phone: (352) 733-2429
Business Email: cami.swartz@neurology.ufl.edu

On This Page

Publications

Academic Articles

  1. Immunophenotyping Tracks Motor Progression in Parkinson’s Disease Associated with a TH Mutation.

    Journal
    Journal of Parkinson's disease.
    Volume/Issue
    14(4):883-888
    [DOI]
    10.3233/JPD-240030.
    [PMID]
    38788089.
    PubMed Publisher’s Site

  2. A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit.

    Journal
    JAMA neurology.
    Volume/Issue
    71(5):543-52
    [DOI]
    10.1001/jamaneurol.2014.131.
    [PMID]
    24664227.
    284 citations PubMed Publisher’s Site

  3. Selection of deep brain stimulation candidates in private neurology practices: referral may be simpler than a computerized triage system.

    Journal
    Neuromodulation : journal of the International Neuromodulation Society.
    Volume/Issue
    15(3):246-50; discussion 250
    [DOI]
    10.1111/j.1525-1403.2012.00437.x.
    [PMID]
    22376158.
    8 citations PubMed Publisher’s Site

  4. Prevalence and characteristics of punding and repetitive behaviors among Parkinson patients in North-Central Florida.

    Journal
    International journal of geriatric psychiatry.
    Volume/Issue
    25(5):540-1
    [DOI]
    10.1002/gps.2324.
    [PMID]
    20391589.
    3 citations PubMed Publisher’s Site

  5. Respiratory response to activation or disinhibition of the dorsal periaqueductal gray in rats.

    Journal
    Journal of applied physiology (Bethesda, Md. : 1985).
    Volume/Issue
    94(3):913-22
    [PMID]
    12571126.
    45 citations PubMed

Grants

  1. A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of NEU-411 in Companion Diagnostic-Positive Participants with Early Parkinsons Disease

    Active

    Role:
    Other
    Funding:
    RHO INC via NEURON23

  2. Ecopipam, encoded EBS-101-TD-391 entitled A Multicenter, Open-Label, Study to Evaluate the Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults with Tourettes Disorder

    Active

    Role:
    Other
    Funding:
    SYNEOS HEALTH via EMALEX BIOSCIENCES

  3. A PHASE IIB, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF INTRAVENOUS PRASINEZUMAB IN PARTICIPANTS WITH EARLY PARKINSON’S DISEASE

    Role:
    Other
    Funding:
    GENENTECH INC

  4. A Phase 3, 4-week, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of TD-9855 in Treating Symptomatic Neurogenic Orthostatic Hypotension in Subjects With Primary Autonomic Failure

    Role:
    Other
    Funding:
    IQVIA Holdings via DRUGDEV INC

  5. Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of 36 Weeks of Treatment with NLY01 in Early-stage Parkinsons Disease

    Role:
    Other
    Funding:
    NEURALY

  6. Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients with ALS: Open-Label Extension for Patients Completing Study 3119002

    Role:
    Other
    Funding:
    PHARMACEUTICAL RES ASSO via ORION CORP

  7. Local Field Potential Beta Adaptive Deep Brain Stimulation Feasibility Study (LFP Beta aDBS Feasibility Study)

    Role:
    Other
    Funding:
    MEDTRONIC INC

Contact Details

Phones:
Business:
(352) 733-2429
Emails:
Business:
cami.swartz@neurology.ufl.edu
Addresses:
Business Mailing:
PO Box 112742
 GAINESVILLE FL 32611
Business Street:
3009 SW WILLISTON RD
 GAINESVILLE FL 32608